Literature DB >> 9342487

Pretransplant renal dysfunction predicts poorer outcome in liver transplantation.

R A Lafayette1, G Paré, C H Schmid, A J King, R J Rohrer, S A Nasraway.   

Abstract

The postoperative courses of 115 liver transplant recipients were reviewed to monitor for outcomes of acute renal failure and mortality. An analysis of baseline (preoperative) variables with particular attention to baseline renal function was accomplished to establish predictive variables for a complicated postoperative course. Acute renal failure requiring dialysis occurred in 27 cases (23%) and was associated with a prolonged ICU stay, greater infectious complications, greater hospital charges and a high mortality rate (46 +/- 11% vs. 9 +/- 3%) as compared to patients who did not experience acute renal failure. Death occurred in 20 patients (17%) overall prior to discharge. In order to assess the contribution of renal function, the population was divided arbitrarily into two groups based on preoperative serum creatinine. Group 1 (n = 50) had a preoperative serum creatinine < 1.0 mg/dl (mean +/- SD = 2.2 +/- 0.2 mg/dl) and Group 2 (n = 65) had a preoperative serum creatinine < or = 1.0 mg/dl (0.7 +/- 0.1 mg/dl). The groups experienced similar operative courses. Group 1 patients experienced significantly longer ICU stays (18 +/- 3 vs. 10 +/- 2 days), higher rates of acute renal failure requiring dialysis (52 +/- 7 vs. 5 +/- 2%), higher hospital charges (231,454 +/- 17,088 vs. 178,755 +/- 14,744 $, US) and a greatly increased mortality rate (32 +/- 1 vs. 6 +/- 1%), as compared to Group 2 patients. A multifactorial regression analysis demonstrated that of all pretransplant factors analyzed, elevation in the serum creatinine was significantly associated and was the strongest predictor of both outcomes: acute renal failure requiring dialysis (ROC = 0.89) and death (ROC = 0.83). The presence or absence of hepatorenal syndrome did not influence the results of this analysis. This study demonstrates that cirrhotic patients with renal dysfunction, as indicated by an elevated serum creatinine, experience a poor surgical outcome following liver transplantation. These patients may require special attention in the perioperative period. Alternatively, these data may influence the selection of ideal candidates for liver transplantation, where scarce resources need to be applied appropriately.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9342487

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  16 in total

1.  Multivariate regression analysis on early mortality after orthotopic liver transplantation.

Authors:  Ye-Ben Qian; Gui-Hua Cheng; Jie-Fu Huang
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

2.  Effects of orthotopic liver transplantation on vasoactive systems and renal function in patients with advanced liver cirrhosis.

Authors:  Concepcíon Cassinello; Enrique Moreno; Adolfo Gozalo; Blanca Ortuño; Beatriz Cuenca; José Antonio Solís-Herruzo
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

3.  The impact of MELD allocation on simultaneous liver-kidney transplantation.

Authors:  Julie A Thompson; John R Lake
Journal:  Curr Gastroenterol Rep       Date:  2009-02

Review 4.  Outcomes of liver transplantation in patients with hepatorenal syndrome.

Authors:  Rohan M Modi; Nishi Patel; Sherif N Metwally; Khalid Mumtaz
Journal:  World J Hepatol       Date:  2016-08-28

Review 5.  Pre-transplant kidney function predicts chronic kidney disease after liver transplant: meta-analysis of observational studies.

Authors:  Fabrizio Fabrizi; Vivek Dixit; Paul Martin; Piergiorgio Messa
Journal:  Dig Dis Sci       Date:  2011-01-08       Impact factor: 3.199

6.  The course of type 1 hepato-renal syndrome post liver transplantation.

Authors:  Paul E Marik; Kelly Wood; Thomas E Starzl
Journal:  Nephrol Dial Transplant       Date:  2005-10-25       Impact factor: 5.992

Review 7.  Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis.

Authors:  Mirela Dobre; Sevag Demirjian; Ashwini R Sehgal; Sankar D Navaneethan
Journal:  Int Urol Nephrol       Date:  2010-03-20       Impact factor: 2.370

Review 8.  Hepatorenal syndrome.

Authors:  Jan Lata
Journal:  World J Gastroenterol       Date:  2012-09-28       Impact factor: 5.742

Review 9.  Acute renal dysfunction in liver diseases.

Authors:  Alex-P Betrosian; Banwari Agarwal; Emmanuel E Douzinas
Journal:  World J Gastroenterol       Date:  2007-11-14       Impact factor: 5.742

10.  Dual Effects of Bilirubin on the Proliferation of Rat Renal NRK52E Cells and ITS Association with Gap Junctions.

Authors:  Yanling Wang; Qiongfang Zhu; Chenfang Luo; Ailan Zhang; Ziqing Hei; Guangjie Su; Zhengyuan Xia; Michael G Irwin
Journal:  Dose Response       Date:  2012-07-30       Impact factor: 2.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.